Bone marrow stromal cells show distinct gene expression patterns depending on symptomatically involved organs in multiple myeloma

被引：2

作者：

Kim, S. Y. ^{[1
,2
]}

Im, K. ^{[3
]}

Park, S. N. ^{[3
]}

Oh, B. ^{[4
]}

Kim, J-A ^{[1
]}

Hwang, S. M. ^{[5
]}

Kim, M. ^{[6
]}

Yoon, S-S ^{[3
,7
]}

Lee, D. S. ^{[1
,3
]}

机构：

[1] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea

[2] Chungnam Natl Univ, Sch Med, Dept Lab Med, Daejeon, South Korea

[3] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea

[4] Asan Med Ctr, Dept Oncol, Seoul, South Korea

[5] Seoul Natl Univ, Bundang Hosp, Dept Lab Med, Seongnam, South Korea

[6] Hallym Univ, Sacred Heart Hosp, Dept Lab Med, Anyang, South Korea

[7] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea

来源：

BLOOD CANCER JOURNAL | 2016年 / 6卷

基金：

新加坡国家研究基金会;

关键词：

DYSCRASIAS; VCAM-1;

D O I：

10.1038/bcj.2016.86

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：e476 / e476

页数：4

共 14 条

[1] Molecular Pathways: VCAM-1 as a Potential Therapeutic Target in Metastasis [J].

Chen, Qing ;

Massague, Joan .

CLINICAL CANCER RESEARCH, 2012, 18 (20) :5520-5525

[2] Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes [J].

Colombo, M. ;

Mirandola, L. ;

Platonova, N. ;

Apicella, L. ;

Basile, A. ;

Figueroa, A. J. ;

Cobos, E. ;

Chiriva-Internati, M. ;

Chiaramonte, R. .

LEUKEMIA, 2013, 27 (05) :1009-1018

[3] Bone marrow mesenchymal stem cells are abnormal in multiple myeloma [J].

Corre, J. ;

Mahtouk, K. ;

Attal, M. ;

Gadelorge, M. ;

Huynh, A. ;

Fleury-Cappellesso, S. ;

Danho, C. ;

Laharrague, P. ;

Klein, B. ;

Reme, T. ;

Bourin, P. .

LEUKEMIA, 2007, 21 (05) :1079-1088

[4] International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma [J].

Dimopoulos, M. ;

Terpos, E. ;

Comenzo, R. L. ;

Tosi, P. ;

Beksac, M. ;

Sezer, O. ;

Siegel, D. ;

Lokhorst, H. ;

Kumar, S. ;

Rajkumar, S. V. ;

Niesvizky, R. ;

Moulopoulos, L. A. ;

Durie, B. G. M. .

LEUKEMIA, 2009, 23 (09) :1545-1556

[5]

Dispenzieri Angela, 2014, Am J Hematol, V89, P214, DOI 10.1002/ajh.23644

[6] Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma [J].

Greenberg, A. J. ;

Rajkumar, S. V. ;

Therneau, T. M. ;

Singh, P. P. ;

Dispenzieri, A. ;

Kumar, S. K. .

LEUKEMIA, 2014, 28 (02) :398-403

[7] Kidney disease associated with plasma cell dyscrasias [J].

Heher, Eliot C. ;

Goes, Nelson B. ;

Spitzer, Thomas R. ;

Raje, Noopur S. ;

Humphreys, Benjamin D. ;

Anderson, Kenneth C. ;

Richardson, Paul G. .

BLOOD, 2010, 116 (09) :1397-1404

[8] Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets [J].

Hideshima, Teru ;

Mitsiades, Constantine ;

Tonon, Giovanni ;

Richardson, Paul G. ;

Anderson, Kenneth C. .

NATURE REVIEWS CANCER, 2007, 7 (08) :585-598

[9]

Merlini G, 2007, CONTRIB NEPHROL, V153, P66

[10] Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1-integrin enhances production of osteoclast-stimulating activity [J].

Michigami, T ;

Shimizu, N ;

Williams, PJ ;

Niewolna, M ;

Dallas, SL ;

Mundy, GR ;

Yoneda, T .

BLOOD, 2000, 96 (05) :1953-1960

← 1 2 →